Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

Stock Information for Arrow Exploration Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Arrow Exploration Corp.

Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength
Covalon Declares First Ever Special Cash Dividend
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025
Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.